Cromwell Property Group Valuation

Is C4Q undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of C4Q when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: C4Q (€0.22) is trading above our estimate of fair value (€0.2)

Significantly Below Fair Value: C4Q is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for C4Q?

Key metric: As C4Q is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for C4Q. This is calculated by dividing C4Q's market cap by their current revenue.
What is C4Q's PS Ratio?
PS Ratio4.6x
SalesAU$219.70m
Market CapAU$1.01b

Price to Sales Ratio vs Peers

How does C4Q's PS Ratio compare to its peers?

The above table shows the PS ratio for C4Q vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.4x
AOX alstria office REIT-AG
5.2x-1.5%€1.2b
HABA Hamborner REIT
4.9x1.7%€515.7m
ABG Abacus Group
5.5x1.2%AU$1.0b
PKST Peakstone Realty Trust
2x4.9%US$477.3m
C4Q Cromwell Property Group
4.6x6.3%€1.0b

Price-To-Sales vs Peers: C4Q is expensive based on its Price-To-Sales Ratio (4.6x) compared to the peer average (4.4x).


Price to Sales Ratio vs Industry

How does C4Q's PS Ratio compare vs other companies in the European Office REITs Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
C4Q 4.6xIndustry Avg. 8.3xNo. of Companies4PS0612182430+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: C4Q is good value based on its Price-To-Sales Ratio (4.6x) compared to the European Office REITs industry average (8.3x).


Price to Sales Ratio vs Fair Ratio

What is C4Q's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

C4Q PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.6x
Fair PS Ratio7.1x

Price-To-Sales vs Fair Ratio: C4Q is good value based on its Price-To-Sales Ratio (4.6x) compared to the estimated Fair Price-To-Sales Ratio (7.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst C4Q forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.22
€0.32
+43.5%
17.9%€0.40€0.28n/a3
Nov ’25€0.23
€0.32
+39.1%
17.9%€0.40€0.28n/a3
Oct ’25€0.27
€0.32
+19.2%
17.9%€0.40€0.28n/a3
Sep ’25€0.24
€0.32
+33.0%
17.9%€0.40€0.28n/a3
Aug ’25€0.24
€0.32
+31.9%
16.9%€0.40€0.28n/a3
Jul ’25€0.24
€0.33
+40.2%
16.0%€0.40€0.28n/a3
Jun ’25€0.25
€0.33
+31.4%
16.0%€0.40€0.28n/a3
May ’25€0.23
€0.33
+42.2%
19.0%€0.42€0.28n/a3
Apr ’25€0.25
€0.33
+35.0%
19.0%€0.42€0.28n/a3
Mar ’25€0.24
€0.38
+60.4%
14.9%€0.42€0.30n/a3
Feb ’25€0.24
€0.39
+63.9%
14.9%€0.43€0.31n/a3
Jan ’25€0.25
€0.39
+56.7%
12.5%€0.42€0.32n/a3
Dec ’24€0.25
€0.39
+56.1%
12.5%€0.42€0.32n/a3
Nov ’24€0.18
€0.39
+115.8%
12.5%€0.42€0.32€0.233
Oct ’24€0.22
€0.43
+97.4%
15.4%€0.51€0.33€0.274
Sep ’24€0.27
€0.46
+70.4%
16.9%€0.53€0.33€0.244
Aug ’24€0.32
€0.48
+50.6%
13.5%€0.55€0.38€0.244
Jul ’24€0.31
€0.52
+66.4%
8.0%€0.56€0.47€0.244
Jun ’24€0.32
€0.52
+63.2%
8.0%€0.56€0.47€0.254
May ’24€0.33
€0.52
+56.8%
8.0%€0.56€0.47€0.234
Apr ’24€0.33
€0.52
+56.9%
8.0%€0.56€0.47€0.254
Mar ’24€0.42
€0.56
+32.9%
9.7%€0.63€0.48€0.244
Feb ’24€0.47
€0.58
+25.3%
7.9%€0.63€0.51€0.244
Jan ’24€0.41
€0.58
+40.8%
7.9%€0.63€0.51€0.254
Dec ’23€0.45
€0.61
+34.5%
8.7%€0.65€0.52€0.254
Nov ’23€0.45
€0.65
+44.1%
6.4%€0.69€0.59€0.184

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies